Who we are

PharmaLex Italy is located in Milan. As with all of the PharmaLex offices, PharmaLex Italy is capable of offering the entire PharmaLex service portfolio to give our customers the same high standards they are used to – no matter where they are in the world.

Flexibility, efficiency, dedication are the principal values of the team, as well as our passion for work. Our aim is to provide effective, high quality services, in accordance with the regulations in force and with the company needs. From simple activities to complex projects, our clients benefit of a strong sense of partnership, teamwork and continuity.

 

P.IVA / C.F. 10092550960
REA: MI-2504242
R.I. Milano-Monza-Brianza-Lodi 10092550960
Capitale sociale € 10.000,00 i.v.

Società soggetta ad attività di direzione e coordinamento esercitata dal socio unico PharmaLex GmbH, Friedrichsdorf (Germania)

PEC: pharmalex@legalmail.it

Local Contact

  • Fulvia Feltrin
    Country Manager Italy PharmaLex Italy S.r.l. Registered office:
    Largo Guido Donegani 2
    20121 Milano - Italia

    Operational office:
    Via Santa Maria Valle, 3
    20123 Milano - Italia
    +39 02 0068 1256

What our clients say about us

We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.

  • Pharmalex provided the resources we needed to compile Investigational Medicinal Product Dossiers for our biological products. The dossiers were delivered on time with the trusted quality we expected

    Small US Biopharmaceutical Company
    Sr Director Regulatory Affairs CMC
  • Thanks so much for your support over the past 30 days. Your commitment and timely communication have made working with you all a pleasant experience.

    US Biotech
    Senior QA Associate
  • In these unprecedented times, PharmaLex continues to support all clients by meeting virtually and providing experienced, remote-based consultants.

    Thomas Dobmeyer, CEO PharmaLex
    CEO PharmaLex
  • There was a close relationship between the regulatory strategy and the writing activities. You developed a fine-tuned regulatory strategy which will be a key factor to smooth the approval of our dossier.

    Large Pharma, Global
    VP Regulatory Strategy